The importance of metabolic markers in the development of a second ischemic stroke
DOI: https://doi.org/10.29296/25877305-2020-10-12
Issue:
10
Year:
2020
Objective. To investigate the relationship between plasma adiponectin (ADN) levels and the rate of
a second noncardioembolic ischemic stroke (IS) over a three-year period Subjects and methods. The cohort
observational study covered 206 patients who had experienced a first noncardioembolic IS, explored the
clinical and metabolic parameters of the participants, and assessed the frequency and date of onset of a
secondary IS using the Cutler-Ederer and Kaplan-Meier methods according to AND concentrations. Fasting
plasma ADN concentrations (μg/ml) were determined using the BioVendor kits (Sweden) on a third-generation
Reader UNIPLAN-9213 microplate photometer (PIKON, Russia). Results. The analysis of the frequency and date
of onset of a second noncardioembolic IS over a three-year period showed an increased risk of its
development in patients with low ADN levels (
Keywords:
neurology
endocrinology
ischemic stroke
adiponectin
second stroke
References:
- Stahovskaja L.V., Kotov S.V., Isakova E.V. Insul't: rukovodstvo dlja vrachej. M.: OOO «Meditsinskoe informatsionnoe agentstvo», 2013; 400 s. [Stakhovskaya L.V., Kotov S.V., Isakova E.V. Insul’t: rukovodstvo dlya vrachei. M.: OOO «Meditsinskoe informatsionnoe agentstvo», 2013; 400 s. (in Russ.)].
- Shishkova V.N. Mehanizmy razvitija serdechno-sosudistyh zabolevanij i saharnogo diabeta tipa 2: rol' insulinorezistentnosti, giperinsulinemii i gipoadiponektinemii. Voprosy korrektsii. Sistemnye gipertenzii. 2014; 11 (2): 48–53 [Shishkova V.N. The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management. Systemic Hypertension. 2014; 11 (2): 48–53 (in Russ.)]. DOI: 10.26442/2075-082X_11.2.48-53
- Arregui M., Buijsse B., Fritsche A. et al. Adiponectin and risk of stroke: prospective study and meta-analysis. Stroke. 2014; 45 (1): 10–7. DOI: 10.1161/STROKEAHA.113.001851 Bang O.Y., Savel J.L., Ovbiagele V. et al. Adiponectin levels in patients with intracranial atherosclerosis. Neurology. 2007; 68 (22): 1931–7. DOI: 10.1212/01.wnl.0000263186.20988.9f
- Shishkova V.N., Adasheva T.V., Remennik A.Ju. i dr. Prognosticheskaja znachimost' kliniko-antropometricheskih, biohimicheskih, metabolicheskih, sosudisto-vospalitel'nyh i molekuljarno-geneticheskih markerov v razvitii pervogo ishemicheskogo insul'ta. Zhurnal nevrol. i psihiatr. im. S.S. Korsakova. 2018; 118 (2): 4–11 [Shishkova V.N., Adasheva T.V., Remenik A.Yu. et al. Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018; 118 (2): 4–11 (in Russ.)]. https://doi.org/10.17116/jnevro2018118214-11
- Dastani Z., Hivert M.F., Timpson N. et al. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals. PLoS. Genet. 2012; 8 (3): e1002607. DOI: 10.1371/journal.pgen.1002607
- Kawai T., Ohishi M., Takeya Ya. et al. Adiponectin single nucleotide polymorphism is a genetic risk factor for stroke trough high pulse wave pressure: a cohort study. J Atheroscler Thromb. 2013; 20 (2): 152–60. DOI: 10.5551/jat.14696
- Chen L., Sun K.X., Juan J. et al. CDH13 genetic polymorphisms, adiponectin and ischemic stroke: a chine family-based sib-pair study. Biomed Environ Sci. 2017; 30 (1): 35–43. DOI: 10.3967/bes2017.004